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The obesity paradox, where the survival of underweight pa-
tients is worse than in patients with a body mass index within
normal reference ranges, has been described in several groups of
patients, particularly those with heart failure or renal failure as well
as in patients with peripheral arterial disease. These studies, all
retrospective and relatively small with just a few thousand patients,
sometimes show an inverse relationship between survival and body
mass index and sometimes a U-shaped curve demonstrating the
highest mortality for very underweight and obese patients.
No prospective studies have been designed to take into con-
sideration the many confounders present in these retrospective
observational studies. These confounders include selection for
treatment, treatments given, the cachexia of cancer, heart failure,
and severe chronic obstructive pulmonary disease, malnourish-
ment, smoking, and diabetes.
Here van Kuijk et al1 describe a retrospective series of patients
undergoing vascular surgical procedures where survival was better
in the overweight and obese patients was than in patients of normal
weight, and survival was worst in the cachectic or underweight
patients. Death is a “hard” end point and reliable for retrospective
studies, but the cause of death is not reliable. Although their Fig 1
suggests that the causes of death could be divided into cardiovas-
cular, noncardiovascular, or unknown, it is difficult enough to
reliably categorize cause of death in prospective studies with an end
point committee and almost impossible to categorize deaths inNutritional status is likely to be an important predictor of
ealing after surgery. It is unsurprising that underweight patients
ave a poor outcome, and in the series reported by van Kuijk et al,1
he prevalence of cancer was higher than in the other groups.
erhaps the high-risk overweight patients were refused surgery,
nderweight patients were refused secondary interventions, or
erhaps overweight patients had more endovascular procedures
nd the underweight patients more open procedures? Also, surpris-
ngly, the overweight patients appeared to have the best medical
anagement of cardiovascular risk factors. Confounders such as
hese serve to highlight the limitations of retrospective studies.
hey are useful for audit and hypothesis generation, but the
ypotheses generated need to be evaluated in prospective studies.
Prospective evaluation of the obesity paradox in vascular sur-
ical patients is likely to require tens of thousands of patients. Is it
orth it? Possibly, if better understanding of the endocrine and
mmune functions of adipose tissue in vascular patients leads to
etter treatment for all patients.2,3
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